Woodward Diversified Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Buy
3,735
+20
+0.5% +$2.63K 0.21% 110
2026
Q1
$511K Buy
3,715
+60
+2% +$8.4K 0.23% 99
2025
Q4
$449K Buy
3,655
+789
+28% +$95.9K 0.21% 110
2025
Q3
$318K Buy
2,866
+10
+0.4% +$1.14K 0.15% 138
2025
Q2
$317K Buy
+2,856
New +$304K 0.16% 130
2024
Q4
Sell
-2,630
Closed -$220K 149
2024
Q3
$220K Buy
+2,630
New +$201K 0.14% 151
2024
Q2
Sell
-2,760
Closed -$202K 163
2024
Q1
$202K Sell
2,760
-1,884
-41% -$145K 0.13% 147
2023
Q4
$376K Sell
4,644
-81
-2% -$6.3K 0.24% 102
2023
Q3
$354K Buy
4,725
+635
+16% +$48.8K 0.26% 97
2023
Q2
$315K Sell
4,090
-466
-10% -$37.2K 0.24% 97
2023
Q1
$378K Sell
4,556
-89
-2% -$7.37K 0.3% 86
2022
Q4
$399K Sell
4,645
-1,177
-20% -$93.2K 0.32% 79
2022
Q3
$359K Sell
5,822
-51
-0.9% -$3.22K 0.3% 85
2022
Q2
$363K Buy
5,873
+578
+11% +$35.8K 0.28% 91
2022
Q1
$315K Buy
5,295
+1,123
+27% +$71.8K 0.21% 115
2021
Q4
$303K Sell
4,172
-277
-6% -$19.1K 0.18% 142
2021
Q3
$311K Buy
4,449
+274
+7% +$19.3K 0.2% 132
2021
Q2
$287K Buy
4,175
+171
+4% +$11.4K 0.16% 148
2021
Q1
$259K Sell
4,004
-357
-8% -$23K 0.15% 156
2020
Q4
$254K Buy
+4,361
New +$263K 0.16% 130

Other funds holding GILD

Woodward Diversified Capital's GILD Position: Q2 2026 in Review

Woodward Diversified Capital increased its Gilead Sciences (GILD) stake by 0.54% in Q2 2026, buying an estimated $2.63K and bringing the position to 3,735 shares worth $472K. The position accounts for 0.21% of the portfolio, ranked #110.

Woodward Diversified Capital first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $511K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Woodward Diversified Capital held 3,735 shares of Gilead Sciences worth $472K as of Q2 2026.
  • Woodward Diversified Capital bought 20 Gilead Sciences shares in Q2 2026, an estimated $2.63K.
  • Gilead Sciences made up 0.21% of Woodward Diversified Capital's portfolio in Q2 2026, its #110 holding.
  • Woodward Diversified Capital first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
  • Woodward Diversified Capital's Gilead Sciences position peaked at $511K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Woodward Diversified Capital's 13F filing for Q2 2026, filed 28 Jul 2026.